Rising Cancer Cases Drive Demand For Cancer Vaccines: Major Factor in the Transformation of the Cancer Vaccines Market in 2025

How Will the Cancer Vaccines Market Grow, and What Is the Projected Market Size?
In recent times, the market size for cancer vaccines has experienced a swift expansion. The growth is expected to go from $7.22 billion in 2024 to $8.25 billion in 2025, with a compound annual growth rate (CAGR) of 14.3%. Factors contributing to this increase during the historic period include the surge in cancer incidences, heightened awareness of cancer vaccines, broadening variety of approved cancer vaccines, mounting evidence about cancer vaccines' effectiveness, and government backing for research and development.

In the coming years, the cancer vaccines market is projected to experience swift expansion, growing to a value of $13.89 billion by 2029 with a compound annual growth rate (CAGR) of 13.9%. Factors contributing to this growth during the forecast period include combination treatments with cancer vaccines, growing investments by pharmaceutical firms, the advent of new biomarkers, and personalized vaccine development. In addition, ongoing expansion of vaccination programs is expected to fuel this growth. Key trends to observe during this forecast period encompass advancements in immunology, the rise of adjuvant therapies, diversification of applications, improved patient access, cooperative research initiatives, breakthroughs in neoantigen-based vaccines, and therapeutic cancer vaccines.

What Key Elements Are Boosting Growth in the Cancer Vaccines Market?
The global increase in cancer instances is expected to fuel the expansion of the cancer vaccines market in the future. As stated by the American Cancer Society in January 2022, it's predicted that there may be 1.9 million new cancer diagnoses and nearly 609,360 cancer-related fatalities in the US. This translates as approximately 1,670 deaths on a daily basis. The most prevalent types of cancer globally include lung, prostate, bowel, and female breast cancer, constituting 43% of all novel cancer instances. Hence, the escalating rates of cancer across the globe are forecasted to stimulate the demand for cancer vaccines in the forthcoming years.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smp

Who Are the Major Industry Players Fueling Cancer Vaccines Market Expansion?
Major companies operating in the cancer vaccines market include GlaxoSmithKline plc, Merck & Co. Inc., Aduro Biotech Inc., AstraZeneca PLC, Dendreon Corporation, Astellas Pharma Inc., Sanofi SA, Sanpower Group, CSL Limited, Pfizer Inc., Serum Institute of India Pvt. Ltd., Advantagene Inc., Advaxis Inc., Agenus Inc., Altor BioScience Corporation, Argos Therapeutics Inc., Oncothyreon Inc., Oncovir Inc., Oxford BioMedica plc., Prima BioMed Ltd., Sotio LLC, Transgene SA, Ubivac LLC, Vaccinogen and Vaxon Biotech, Bavarian Nordic A/S, Bharat Biotech International Limited, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, Emergent BioSolutions Inc., Galena Biopharma Inc., Moderna Inc., Biothera Pharmaceuticals Inc., Celldex Therapeutics Inc., Genexine Inc., Gritstone Oncology Inc., Heat Biologics Inc., ISA Pharmaceuticals B.V., Northwest Biotherapeutics Inc., OncBioMune Pharmaceuticals Inc., TapImmune Inc., Vaxil Bio Ltd., VBI Vaccines Inc., Ziopharm Oncology Inc.

Which Key Developments Are Influencing the Cancer Vaccines Market?
The growing popularity of alternative treatment methods and natural cures around the world is predicted to impact the earnings of cancer vaccine production entities negatively. The rise in preference for homeopathy, Ayurveda, yoga, acupuncture, and sujok therapy reflects a gradual transition away from some conventional hospital procedures. For example, Ayurvedic medicine, a timeless Indian medical system, offers various cancer treatment techniques and therapies. The World Health Organization (WHO) reports that many countries still rely primarily on plant-based treatments, with developing countries harnessing the therapeutic advantages of natural compounds, leading to a decrease in cancer vaccine sales. Furthermore, the worldwide homeopathic product market is expected to hit $18.6 billion by 2027. This trend is forecasted to persist, thereby reducing the demand for cancer vaccines.

How Is the Segmentation of the Cancer Vaccines Market Defined?
The cancer vaccines market covered in this report is segmented -

1) By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
2) By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines
3) By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types
4) By End-User: Cancer Treatment Centers, Research Institutes

Subsegments:
1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines
2) By Therapeutic Cancer Vaccines: Sipuleucel-T (Provenge), Talimogene Laherparepvec (T-VEC), Other Therapeutic Vaccines

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

What Is the Leading Region in the Cancer Vaccines Market?
The countries covered in the cancer vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Is Covered In The Cancer Vaccines Global Market Report?

- Market Size Analysis: Analyze the Cancer Vaccines Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Cancer Vaccines Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Cancer Vaccines Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Cancer Vaccines Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3452

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.